Luyan Pharma Co.,Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2021
April 27, 2021 at 10:09 am
Share
Luyan Pharma Co.,Ltd. announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced sales was CNY 4,165.230 million compared to CNY 3,360.924 million a year ago. Operating income was CNY 84.438 million compared to CNY 69.197 million a year ago. Net income was CNY 64.700 million compared to CNY 51.218 million a year ago. Basic earnings per share from continuing operations was CNY 0.17 compared to CNY 0.15 a year ago. For the full year, sales was CNY 15,531.278 million compared to CNY 15,008.876 million a year ago. Operating income was CNY 374.730 million compared to CNY 346.131 million a year ago. Net income was CNY 267.525 million compared to CNY 255.888 million a year ago. Basic earnings per share from continuing operations was CNY 0.74 compared to CNY 0.73 a year ago.
Luyan Pharma Co., Ltd., formerly LUYAN (FUJIAN) PHARMA CO., LTD. is principally engaged in the distribution and pharmaceutical retail chain business of medicine, Chinese herbal medicine, medical instrument and the second type vaccine. The Company makes Fujian Province as its major target market and provides its products directly to medical institutions at all levels.